Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (11)

« Back to Publications

Estimated Doses to the Heart, Lungs and Oesophagus and Risks From Typical UK Radiotherapy for Early Breast Cancer During 2015-2023.

Holt F. et al, (2024), Clin Oncol (R Coll Radiol), 36, e322 - e332

Individualised Estimation of Quality-adjusted Survival Benefit and Cost-effectiveness of Proton Beam Therapy in Intermediate-stage Hodgkin Lymphoma.

Jones DA. et al, (2023), Clin Oncol (R Coll Radiol), 35, 301 - 310

Proton Therapy in Supradiaphragmatic Lymphoma: Predicting Treatment-Related Mortality to Help Optimize Patient Selection.

Ntentas G. et al, (2022), Int J Radiat Oncol Biol Phys, 112, 913 - 925

Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry.

Jones DA. et al, (2022), Blood Adv, 6, 909 - 919

Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma.

Cutter DJ. et al, (2021), J Clin Oncol, 39, 3591 - 3601

The role of motion management and position verification in lymphoma radiotherapy.

Aznar M. et al, (2021), Br J Radiol, 94

Exposure of the oesophagus in breast cancer radiotherapy: A systematic review of oesophagus doses published 2010-2020.

Duane FK. et al, (2021), Radiother Oncol, 164, 261 - 267

Dose-response relationships for radiation-related heart disease: Impact of uncertainties in cardiac dose reconstruction.

Ntentas G. et al, (2020), Radiother Oncol, 153, 155 - 162

Clinical Intensity Modulated Proton Therapy for Hodgkin Lymphoma: Which Patients Benefit the Most?

Ntentas G. et al, (2019), Pract Radiat Oncol, 9, 179 - 187

Cardiac Radiation Dose Reconstruction in the Study of Late Effects: A Comparison of Different Methods

Ntentas G. et al, (2018), RADIOTHERAPY AND ONCOLOGY, 127, S1091 - S1092

Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines.

van Nimwegen FA. et al, (2017), Blood, 129, 2257 - 2265